ADVANTAL
LIVE

Serial Number

79420116

Owner

STE GROUP KEYCORP S.L.

Filing Date

Dec 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ADVANTAL Trademark

Serial Number: 79420116

ADVANTAL is a trademark filed by STE GROUP KEYCORP S.L. on December 13, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

STE GROUP KEYCORP S.L. (3 trademarks)

AVDA. UNIVERSITAT AUTONOMA, 13

Entity Type: 98

Trademark Details

Filing Date

December 13, 2024

Registration Date

Not Registered

Goods & Services

Sanitary products for medical use; sanitary products for cough treatment and for upper respiratory tract care; medical syrups and syrups for pharmaceutical use; tranquillizers; nutritional supplements; medicines for medical use; cough drops, tablets and syrups for medical use; sprays for medical purposes; ointments for medical use; pomades for medical use; mineral, dietetic, vitamin and nutritional food supplements; dietetic foods for medical use; all the aforesaid goods for human use.

Scientific and technological services for medical purposes for humans; research and design services in the field of human medicine; research and development of new products for third parties.

Wholesale and retail services in stores, via electronic media and computer networks for pharmaceutical products for human use, medical and non-medicinal preparations, nutritional supplements, food supplements in general, medicines for medical use; import-export agency services.

Filing History

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 20, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 20, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 27, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 26, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 24, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 23, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 27, 2025 REPR